Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

SAB Biotherapeutics (SABS) Receivables - Other (2020 - 2021)

SAB Biotherapeutics (SABS) has disclosed Receivables - Other for 2 consecutive years, with $6250.0 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Receivables - Other changed 0.0% year-over-year to $6250.0, compared with a TTM value of $6250.0 through Dec 2021, changed 0.0%, and an annual FY2021 reading of $6250.0, changed 0.0% over the prior year.
  • Receivables - Other was $6250.0 for Q4 2021 at SAB Biotherapeutics, roughly flat from $6250.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $6250.0 in Q4 2020 and bottomed at $6250.0 in Q4 2020.